Why the Amanta Healthcare IPO Could Be a Smart Pick This Week - अमंता हेल्थकेअर IPO – गुंतवणुकीपूर्वी जाणून घ्या महत्वाचे मुद्दे
Amanta Healthcare IPO – All You Need to Know
Comprehensive details on price band, dates, lot size, issue structure, company profile, and how to apply. Last updated: 02 Sep 2025
Quick Highlights
Ticker / Exchange: Amanta Healthcare Ltd. • NSE / BSE
Issue Structure: 100% Fresh Issue • QIB ~50%NII ~15%Retail ~35%
GMP (Unofficial): ~₹15–₹22 (indicative; not a guarantee)
Note: GMP and day-wise subscription numbers below are indicative and change frequently. Always verify on official sources before making decisions.
Timeline
| IPO Opens | Mon, 01 Sep 2025 |
| IPO Closes | Wed, 03 Sep 2025 |
| Basis of Allotment (Tentative) | Thu, 04 Sep 2025 |
| Refunds / Demat Credit (Tentative) | Fri–Mon, 05–08 Sep 2025 |
| Listing Date (Tentative) | Mon, 08 Sep 2025 or Tue, 09 Sep 2025 |
| Registrar | Update registrar name here |
IPO Details
| Face Value | ₹10 per share |
| Price Band | ₹120 – ₹126 |
| Market Lot | 119 shares per lot |
| Minimum / Maximum (Retail) | 1 lot (119 shares) / 13 lots (as per rules) |
| Issue Size | ₹126 crore (Fresh Issue of 1 crore shares) |
| Offer for Sale (OFS) | Nil |
| Promoter Holding | Update pre/post % if disclosed |
| Listing | NSE & BSE |
Company Overview
Amanta Healthcare Ltd. (founded 1994) manufactures sterile liquid formulations—IV fluids, diluents, ophthalmic & respiratory care, irrigation solutions—using advanced ABFS and ISBM technologies. The company serves India via branded distribution and also exports across multiple countries from a WHO-GMP compliant facility in Gujarat.
Edit this paragraph if you want to add product examples or distribution footprint numbers.
Financial Highlights (₹ crore)
| Revenue (FY2025) | 276.09 |
| Revenue (FY2024) | 281.61 |
| PAT (FY2025) | 10.50 |
| PAT (FY2024) | 3.63 |
| Employees (as of Mar 31, 2025) | ~1,718 |
Source: DRHP/RHP & market reports. Replace with audited numbers if you have the final RHP.
Use of Proceeds
- New SteriPort manufacturing line (approx. ₹70 crore)
- SVP line expansion at Hariyala facility (approx. ₹30.13 crore)
- General corporate purposes
Key Risks
- Single-site dependency: Concentration at one manufacturing facility.
- Regulatory exposure: Pharma is highly regulated; compliance costs and approvals impact timelines.
- Valuation sensitivity: At the upper band, implied multiples may be rich; monitor peer comparisons.
- Export markets: FX and global demand variability.
Day-wise Subscription (Indicative)
| Day 1 | Overall: ~4.6x • Retail: ~6.7x • NII: ~5.8x • QIB: ~0.04x |
| Day 2 | Update here |
| Day 3 | Update here |
Tip: Replace with live data from exchange filings during the issue.
How to Apply (UPI / ASBA)
- Log in to your broker app or netbanking ASBA portal.
- Select IPO → choose Amanta Healthcare.
- Enter lots (min 1) and price (cut-off recommended for retail).
- Confirm and approve mandate on your UPI app.
- Track status: order book & mandate until allotment.
FAQs
What is the lot size? The market lot is 119 shares. Retail minimum is 1 lot.
What is the price band? ₹120 to ₹126 per share (face value ₹10).
When is listing? Tentatively 08–09 Sep 2025 (subject to approvals).
Is this investment advice? No. This article is for information only.
Disclaimer: IPO investing is subject to market risk. Grey Market Premium (GMP) is unofficial, volatile, and not a reliable indicator of listing performance. Please verify final details from the RHP/Exchange before applying.
